All In Biotech

Free tool

FAERS Monitor: Mucinex D

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021585 or its brand name (Mucinex D, Guaifenesin, Pseudoephedrine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

1,816

Serious

694

38% of reports

Hospitalization

213

Death reported

58

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective147
  • insomnia146
  • dizziness129
  • headache112
  • nausea108
  • fatigue105
  • dyspnoea85
  • accidental overdose76
  • cough72
  • sinusitis71
  • diarrhoea69
  • pain68
  • overdose64
  • anxiety63
  • vomiting59

Reports by year received

View as table
YearReports
20052
20066
20073
20088
200920
201058
201134
201252
201378
201459
2015132
2016227
2017223
2018175
2019147
2020151
202157
202296
202396
202487
202579
202626

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,343 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
accidental overdoseSignal7624.119.31,660
sinusitisSignal718.06.4432
insomniaSignal1466.45.4661
overdoseSignal643.42.7109
dizzinessSignal1293.02.5174
coughSignal723.02.494
anxietySignal632.62.059
headacheSignal1122.11.763
dyspnoea851.71.427
nausea1081.61.323
fatigue1051.61.321
vomiting591.51.18
drug ineffective1471.31.110
pain681.31.04
diarrhoea691.21.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.